Last reviewed · How we verify
Anemia due to and following chemotherapy
Approved treatments
- Aranesp · University of Washington
- Aranesp · Amgen
Aranesp works by binding to the erythropoietin receptor, mimicking the action of natural erythropoietin to stimulate red blood cell production. - Darbepoetin · NICHD Neonatal Research Network
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Anemia due to and following chemotherapy patent landscape — cliff calendar, originator estates, attackable patents
- Anemia due to and following chemotherapy treatment landscape brief
- Anemia due to and following chemotherapy treatment updates RSS
Frequently asked questions about Anemia due to and following chemotherapy
What drugs treat Anemia due to and following chemotherapy?
Tracked treatments include Aranesp, Darbepoetin.
What is the treatment for Anemia due to and following chemotherapy?
Standard treatment for Anemia due to and following chemotherapy includes Aranesp, Darbepoetin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Anemia due to and following chemotherapy patent cliff · Anemia due to and following chemotherapy CI report
- Treatment: Aranesp · University of Washington
- Treatment: Aranesp · Amgen
- Treatment: Darbepoetin · NICHD Neonatal Research Network
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing